{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:41:43Z","timestamp":1794328903691,"version":"4.9.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-74400-w","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:01:48Z","timestamp":1728043308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson\u2019s disease: results from an open label single-arm study"],"prefix":"10.1038","volume":"14","author":[{"given":"V.","family":"Andreozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Erro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Barbella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Memoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Squillante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Guglielmetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Iovino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Pellecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"key":"74400_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano, A., Visanji, N. P., Liu, L. W., Lang, A. E. & Pfeiffer, R. F. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol.14, 625\u2013639 (2015).","journal-title":"Lancet Neurol."},{"issue":"1","key":"74400_CR2","first-page":"60","volume":"117","author":"K Krogh","year":"2008","unstructured":"Krogh, K., Ostergaard, K., Sabroe, S. & Laurberg, S. Clinical aspects of bowel symptoms in Parkinson\u2019s disease. Acta Neurol. Scand.117(1), 60\u201364 (2008).","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"74400_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans, F. et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov. Disord.30(3), 350\u2013358 (2015).","journal-title":"Mov. Disord."},{"issue":"1","key":"74400_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin, C. H. et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J. Neuroinflammation16(1), 129. https:\/\/doi.org\/10.1186\/s12974-019-1528-y (2019).","journal-title":"J. Neuroinflammation"},{"key":"74400_CR5","doi-asserted-by":"publisher","first-page":"636545","DOI":"10.3389\/fnagi.2021.636545","volume":"13","author":"T Shen","year":"2021","unstructured":"Shen, T. et al. The Association between the gut microbiota and Parkinson\u2019s Disease, a meta -analysis. Front. Aging Neurosci.13, 636545 (2021).","journal-title":"Front. Aging Neurosci."},{"issue":"6571","key":"74400_CR6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1126\/science.abi6087","volume":"374","author":"G Agirman","year":"2021","unstructured":"Agirman, G., Yu, K. B. & Hsiao, E. Y. Signaling inflammation across the gut-brain axis. Science374(6571), 1087\u20131092. https:\/\/doi.org\/10.1126\/science.abi6087 (2021).","journal-title":"Science"},{"issue":"11","key":"74400_CR7","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00535-012-0627-7","volume":"47","author":"C Stasi","year":"2012","unstructured":"Stasi, C., Rosselli, M., Bellini, M., Laffi, G. & Milani, S. Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: The top-down and the bottom-up model. J. Gastroenterol.47(11), 1177\u20131185 (2012).","journal-title":"J. Gastroenterol."},{"issue":"37","key":"74400_CR8","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","volume":"21","author":"A Mulak","year":"2015","unstructured":"Mulak, A. & Bonaz, B. Brain-gut-microbiota axis in Parkinson\u2019s disease. World J. Gastroenterol.21(37), 10609\u201310620 (2015).","journal-title":"World J. Gastroenterol."},{"key":"74400_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill, C. et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol.11, 506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"74400_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.7","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson, G. R. et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol.14(8), 491\u2013502. https:\/\/doi.org\/10.1038\/nrgastro.2017.7 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"74400_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","volume":"17","author":"KS Swanson","year":"2020","unstructured":"Swanson, K. S. et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of symbiotics. Nat. Rev. Gastroenterol. Hepatol.17(11), 687\u2013701. https:\/\/doi.org\/10.1038\/s41575-020-0344-2 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"74400_CR12","doi-asserted-by":"publisher","first-page":"1007654","DOI":"10.3389\/fphar.2022.1007654","volume":"13","author":"L Xie","year":"2023","unstructured":"Xie, L., Chen, D., Zhu, X. & Cheng, C. Efficacy and safety of probiotics in Parkinson\u2019s constipation: A systematic review and meta-analysis. Front. Pharmacol.13, 1007654. https:\/\/doi.org\/10.3389\/fphar.2022.1007654 (2023).","journal-title":"Front. Pharmacol."},{"key":"74400_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jad.2019.04.043","volume":"252","author":"N Tran","year":"2019","unstructured":"Tran, N. et al. The gut-brain relationship: Investigating the effect of multispecies probiotics on anxiety in a randomized placebo-controlled trial of healthy young adults. J. Affect. Disord.252, 271\u2013277. https:\/\/doi.org\/10.1016\/j.jad.2019.04.043 (2019).","journal-title":"J. Affect. Disord."},{"key":"74400_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbi.2015.04.003","volume":"48","author":"L Steenbergen","year":"2015","unstructured":"Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J. A. & Colzato, L. S. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav. Immun.48, 258\u2013264. https:\/\/doi.org\/10.1016\/j.bbi.2015.04.003 (2015).","journal-title":"Brain Behav. Immun."},{"key":"74400_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jff.2014.07.007","volume":"10","author":"Y-C Chung","year":"2014","unstructured":"Chung, Y.-C. et al. Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J. Funct. Foods10, 465\u2013474. https:\/\/doi.org\/10.1016\/j.jff.2014.07.007 (2014).","journal-title":"J. Funct. Foods"},{"issue":"6","key":"74400_CR16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3920\/BM2017.0193","volume":"9","author":"T Inoue","year":"2018","unstructured":"Inoue, T. et al. Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects. Benef. Microbes9(6), 843\u2013853. https:\/\/doi.org\/10.3920\/BM2017.0193 (2018).","journal-title":"Benef. Microbes"},{"issue":"2","key":"74400_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/nu11020305","volume":"11","author":"YH Hwang","year":"2019","unstructured":"Hwang, Y. H. et al. Efficacy and safety of Lactobacillus Plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: A 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrients11(2), 305. https:\/\/doi.org\/10.3390\/nu11020305 (2019).","journal-title":"Nutrients"},{"issue":"5","key":"74400_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3920\/BM2018.0170","volume":"10","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi, Y., Kuhara, T., Oki, M. & Xiao, J. Z. Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: A randomised, double-blind, placebo-controlled trial. Benef. Microbes10(5), 511\u2013520. https:\/\/doi.org\/10.3920\/BM2018.0170 (2019).","journal-title":"Benef. Microbes"},{"key":"74400_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fneur.2018.00662","volume":"9","author":"A Agahi","year":"2018","unstructured":"Agahi, A. et al. Does severity of Alzheimer\u2019s disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Front. Neurol.9, 662. https:\/\/doi.org\/10.3389\/fneur.2018.00662 (2018).","journal-title":"Front. Neurol."},{"key":"74400_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari, E. et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: a randomized, double-blind and controlled trial. Front. Aging Neurosci.8, 256. https:\/\/doi.org\/10.3389\/fnagi.2016.00256 (2016).","journal-title":"Front. Aging Neurosci."},{"issue":"6","key":"74400_CR21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.clnu.2018.11.034","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji, O. R. et al. Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer\u2019s disease: A randomized, double-blind, controlled trial. Clin. Nutr.38(6), 2569\u20132575. https:\/\/doi.org\/10.1016\/j.clnu.2018.11.034 (2019).","journal-title":"Clin. Nutr."},{"issue":"10","key":"74400_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fmicb.2019.00324","volume":"21","author":"Y Ou","year":"2019","unstructured":"Ou, Y. et al. Lactobacillus casei strain shirota alleviates constipation in adults by increasing the pipecolinic acid level in the gut. Front. Microbiol.21(10), 324. https:\/\/doi.org\/10.3389\/fmicb.2019.00324 (2019).","journal-title":"Front. Microbiol."},{"issue":"11","key":"74400_CR23","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1136\/gutjnl-2016-313271","volume":"66","author":"D Vandeputte","year":"2017","unstructured":"Vandeputte, D. et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut66(11), 1968\u20131974. https:\/\/doi.org\/10.1136\/gutjnl-2016-313271 (2017).","journal-title":"Gut"},{"key":"74400_CR24","unstructured":"https:\/\/theromefoundation.org\/rome-iv\/rome-iv-criteria\/ consulted on 4 July (2023)."},{"key":"74400_CR25","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord.23, 2129\u20132170. https:\/\/doi.org\/10.1002\/mds.22340 (2008).","journal-title":"Mov. Disord."},{"issue":"11","key":"74400_CR26","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser, M., Marinus, J., Stiggelbout, A. M. & Van Hilten, J. J. Assessment of autonomic dysfunction in Parkinson\u2019s disease: The SCOPA-AUT. Mov. Disord.19(11), 1306\u20131312. https:\/\/doi.org\/10.1002\/mds.20153 (2004).","journal-title":"Mov. Disord."},{"key":"74400_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc.53, 695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x (2005).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"4","key":"74400_CR28","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jrp.2009.03.009","volume":"43","author":"D Leising","year":"2009","unstructured":"Leising, D., Grande, T. & Faber, R. The Toronto Alexithymia Scale (TAS-20): A measure of general psychological distress. J. Res. Personal.43(4), 707\u2013710. https:\/\/doi.org\/10.1016\/j.jrp.2009.03.009 (2009).","journal-title":"J. Res. Personal."},{"key":"74400_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.021","volume":"28","author":"F Assogna","year":"2016","unstructured":"Assogna, F. et al. Alexithymia in Parkinson\u2019s disease: A systematic review of the literature. Parkinsonism Relat. Disord.28, 1\u201311. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.03.021 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"74400_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1469-7610.00715","volume":"42","author":"S Baron-Cohen","year":"2001","unstructured":"Baron-Cohen, S., Wheelwright, S., Hill, J., Raste, Y. & Plumb, I. The, \u201cReading the Mind in the Eyes\u201d test revised version: A study with normal adults, and adults with Asperger syndrome or high-functioning autism. J. Child Psychol. Psychiatry42(2), 241\u2013251 (2001).","journal-title":"J. Child Psychol. Psychiatry"},{"issue":"8","key":"74400_CR31","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/mds.25919","volume":"29","author":"AF Leentjens","year":"2014","unstructured":"Leentjens, A. F. et al. The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale. Mov. Disord.29(8), 1035\u20131043. https:\/\/doi.org\/10.1002\/mds.25919 (2014).","journal-title":"Mov. Disord."},{"key":"74400_CR32","doi-asserted-by":"crossref","unstructured":"Spielberger, C., Gorsuch, R., Lushene, R., Vagg, P. R., & Jacobs, G. Manual for the State-Trait Anxiety Inventory (Form Y1 \u2013 Y2) (1983).","DOI":"10.1037\/t06496-000"},{"key":"74400_CR33","volume-title":"Manual for the Beck Depression Inventory-II","author":"AT Beck","year":"1996","unstructured":"Beck, A. T., Steer, R. A. & Brown, G. K. Manual for the Beck Depression Inventory-II (Psychological Corporation, 1996)."},{"issue":"1","key":"74400_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry23(1), 56\u201362. https:\/\/doi.org\/10.1136\/jnnp.23.1.56 (1960).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"74400_CR35","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/003655299750025327","volume":"34","author":"L Frank","year":"1999","unstructured":"Frank, L., Kleinman, L., Farup, C., Taylor, L. & Miner, P. Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand. J. Gastroenterol.34, 870\u2013877 (1999).","journal-title":"Scand. J. Gastroenterol."},{"key":"74400_CR36","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis, S. J. & Heaton, K. W. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol.32, 920\u2013924 (1997).","journal-title":"Scand. J. Gastroenterol."},{"issue":"5","key":"74400_CR37","doi-asserted-by":"publisher","first-page":"e14092","DOI":"10.1111\/nmo.14092","volume":"33","author":"G Oliviero","year":"2021","unstructured":"Oliviero, G. et al. Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress. Neurogastroenterol. Motil.33(5), e14092. https:\/\/doi.org\/10.1111\/nmo.14092 (2021).","journal-title":"Neurogastroenterol. Motil."},{"issue":"2","key":"74400_CR38","doi-asserted-by":"publisher","first-page":"2274128","DOI":"10.1080\/19490976.2023.2274128","volume":"15","author":"G Gargari","year":"2023","unstructured":"Gargari, G. et al. Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: A potential clinically relevant stratification factor based on catabotyping analysis. Gut Microbes15(2), 2274128. https:\/\/doi.org\/10.1080\/19490976.2023.2274128 (2023).","journal-title":"Gut Microbes"},{"issue":"9","key":"74400_CR39","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1111\/1462-2920.14271","volume":"20","author":"G Gargari","year":"2018","unstructured":"Gargari, G. et al. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome. Environ. Microbiol.20(9), 3201\u20133213. https:\/\/doi.org\/10.1111\/1462-2920.14271 (2018).","journal-title":"Environ. Microbiol."},{"issue":"8","key":"74400_CR40","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s10571-021-01128-w","volume":"42","author":"H Mirzaei","year":"2022","unstructured":"Mirzaei, H. et al. Probiotics and the treatment of Parkinson\u2019s disease: An update. Cell. Mol. Neurobiol.42(8), 2449\u20132457. https:\/\/doi.org\/10.1007\/s10571-021-01128-w (2022).","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"74400_CR41","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1212\/WNL.0000000000010998","volume":"96","author":"AH Tan","year":"2021","unstructured":"Tan, A. H. et al. Probiotics for constipation in parkinson disease: A randomized placebo-controlled study. Neurology96(5), e772\u2013e782 (2021).","journal-title":"Neurology"},{"key":"74400_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.parkreldis.2022.08.022","volume":"103","author":"Y Du","year":"2022","unstructured":"Du, Y. et al. Probiotics for constipation and gut microbiota in Parkinson\u2019s disease. Parkinsonism Relat. Disord.103, 92\u201397. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.08.022 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"74400_CR43","doi-asserted-by":"publisher","first-page":"e0244680","DOI":"10.1371\/journal.pone.0244680","volume":"15","author":"A Ibrahim","year":"2020","unstructured":"Ibrahim, A. et al. Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson\u2019s disease: A randomised controlled trial. PloS one15(12), e0244680. https:\/\/doi.org\/10.1371\/journal.pone.0244680 (2020).","journal-title":"PloS one"},{"issue":"2","key":"74400_CR44","first-page":"117","volume":"57","author":"E Cassani","year":"2011","unstructured":"Cassani, E. et al. Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients. Minerva Gastroenterol. e Dietol.57(2), 117\u2013121 (2011).","journal-title":"Minerva Gastroenterol. e Dietol."},{"issue":"12","key":"74400_CR45","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","volume":"87","author":"L Iorio","year":"2016","unstructured":"Iorio, L. et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT. Neurology87(12), 1274\u20131280. https:\/\/doi.org\/10.1212\/WNL.0000000000003127 (2016).","journal-title":"Neurology"},{"issue":"12","key":"74400_CR46","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","volume":"87","author":"M Barichella","year":"2016","unstructured":"Barichella, M. et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT. Neurology87(12), 1274\u20131280. https:\/\/doi.org\/10.1212\/WNL.0000000000003127 (2016).","journal-title":"Neurology"},{"issue":"12","key":"74400_CR47","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1271\/bbb.64.2706","volume":"64","author":"F Nagao","year":"2000","unstructured":"Nagao, F., Nakayama, M., Muto, T. & Okumura, K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects. Biosci. Biotechnol. Biochem.64(12), 2706\u20132708. https:\/\/doi.org\/10.1271\/bbb.64.2706 (2000).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"74400_CR48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00217-010-1255-1","volume":"231","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. The antioxidative effects of probiotic Lactobacillus casei Zhang on the hyperlipidemic rats. Eur. Food Res. Technol.231, 151\u2013158. https:\/\/doi.org\/10.1007\/s00217-010-1255-1 (2010).","journal-title":"Eur. Food Res. Technol."},{"issue":"5","key":"74400_CR49","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jbiosc.2010.05.016","volume":"110","author":"K Matsumoto","year":"2010","unstructured":"Matsumoto, K. et al. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J. Biosci. Bioeng.110(5), 547\u2013552. https:\/\/doi.org\/10.1016\/j.jbiosc.2010.05.016 (2010).","journal-title":"J. Biosci. Bioeng."},{"issue":"6","key":"74400_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/etm.2020.9315","volume":"20","author":"OB B\u0103rboi","year":"2020","unstructured":"B\u0103rboi, O. B., Ciortescu, I., Chiril\u0103, I., Anton, C. & Drug, V. Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review). Exp. Ther. Med.20(6), 185. https:\/\/doi.org\/10.3892\/etm.2020.9315 (2020).","journal-title":"Exp. Ther. Med."},{"key":"74400_CR51","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/s41380-022-01479-w","volume":"27","author":"AP Shoubridge","year":"2022","unstructured":"Shoubridge, A. P. et al. The gut microbiome and mental health: Advances in research and emerging priorities. Mol. Psychiatry27, 1908\u20131919. https:\/\/doi.org\/10.1038\/s41380-022-01479-w (2022).","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"74400_CR52","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1017\/S0007114510004319","volume":"105","author":"M Messaoudi","year":"2011","unstructured":"Messaoudi, M. et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr.105(5), 755\u2013764. https:\/\/doi.org\/10.1017\/S0007114510004319 (2011).","journal-title":"Br. J. Nutr."},{"issue":"2","key":"74400_CR53","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.clnu.2018.04.010","volume":"38","author":"A Kazemi","year":"2019","unstructured":"Kazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H. & Djafarian, K. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clin. Nutr.38(2), 522\u2013528. https:\/\/doi.org\/10.1016\/j.clnu.2018.04.010 (2019).","journal-title":"Clin. Nutr."},{"issue":"4","key":"74400_CR54","doi-asserted-by":"publisher","first-page":"19m02578","DOI":"10.4088\/PCC.19m02578","volume":"22","author":"A Saccarello","year":"2020","unstructured":"Saccarello, A. et al. Oral administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 improves the mild-to-moderate symptoms of depression: A randomized, double-blind, placebo-controlled study. Prim. Care Companion CNS Disord.22(4), 19m02578. https:\/\/doi.org\/10.4088\/PCC.19m02578 (2020).","journal-title":"Prim. Care Companion CNS Disord."},{"issue":"11","key":"74400_CR55","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/nu13113731","volume":"13","author":"HM Chen","year":"2021","unstructured":"Chen, H. M. et al. Psychophysiological effects of Lactobacillus plantarum PS128 in patients with major depressive disorder: A preliminary 8-week open trial. Nutrients13(11), 3731. https:\/\/doi.org\/10.3390\/nu13113731 (2021).","journal-title":"Nutrients"},{"issue":"1","key":"74400_CR56","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1757-4749-1-6","volume":"1","author":"AV Rao","year":"2009","unstructured":"Rao, A. V. et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog.1(1), 6. https:\/\/doi.org\/10.1186\/1757-4749-1-6 (2009).","journal-title":"Gut Pathog."},{"issue":"1","key":"74400_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41531-022-00327-6","volume":"8","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. Probiotics synergized with conventional regimen in managing Parkinson\u2019s disease. NPJ Parkinsons Dis.8(1), 62. https:\/\/doi.org\/10.1038\/s41531-022-00327-6 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"74400_CR58","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4087361","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Effect of Lacticaseibacillus Paracasei strain shirota supplementation on clinical responses, gut microbiota and faecal metabolites in patients with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Lacticaseibacillus Paracaseihttps:\/\/doi.org\/10.2139\/ssrn.4087361 (2022).","journal-title":"Lacticaseibacillus Paracasei"},{"key":"74400_CR59","doi-asserted-by":"publisher","first-page":"650053","DOI":"10.3389\/fnut.2021.650053","volume":"8","author":"CS Lu","year":"2021","unstructured":"Lu, C. S. et al. The add-on effect of Lactobacillus plantarum PS128 in patients with parkinson\u2019s Disease: A pilot study. Front. Nutr.8, 650053. https:\/\/doi.org\/10.3389\/fnut.2021.650053 (2021).","journal-title":"Front. Nutr."},{"issue":"3","key":"74400_CR60","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji, O. R. et al. Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Clin. Nutr.38(3), 1031\u20131035. https:\/\/doi.org\/10.1016\/j.clnu.2018.05.018 (2019).","journal-title":"Clin. Nutr."},{"issue":"3","key":"74400_CR61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1176\/appi.neuropsych.14070169","volume":"27","author":"L Ricciardi","year":"2015","unstructured":"Ricciardi, L. et al. Alexithymia in neurological disease: A review. J. Neuropsychiatry Clin. Neurosci.27(3), 179\u2013187. https:\/\/doi.org\/10.1176\/appi.neuropsych.14070169 (2015).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"6","key":"74400_CR62","doi-asserted-by":"publisher","first-page":"e0131470","DOI":"10.1371\/journal.pone.0131470","volume":"10","author":"I Enrici","year":"2015","unstructured":"Enrici, I. et al. Emotion processing in Parkinson\u2019s disease: A three-level study on recognition, representation and regulation. PLoS ONE10(6), e0131470 (2015).","journal-title":"PLoS ONE"},{"key":"74400_CR63","series-title":"International university series in psychology","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1037\/11374-006","volume-title":"A handbook of general experimental psychology","author":"P Bard","year":"1934","unstructured":"Bard, P. Emotion: I The Neuro-humoral Basis of Emotional Reactions. In A handbook of general experimental psychology 264\u2013311 (Clark University Press, 1934)."},{"key":"74400_CR64","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/cercor\/bhs077","volume":"23","author":"A Damasio","year":"2013","unstructured":"Damasio, A., Damasio, H. & Tranel, D. Persistence of feelings and sentience after bilateral damage of the insula. Cereb. Cortex23, 833\u2013846 (2013).","journal-title":"Cereb. Cortex"},{"key":"74400_CR65","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1176\/appi.ajp.2016.16030353","volume":"173","author":"JE LeDoux","year":"2016","unstructured":"LeDoux, J. E. & Pine, D. S. Using neuroscience to help understand fear and anxiety: A two-system framework. Am. J. Psychiatry173, 1083\u20131093 (2016).","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"74400_CR66","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3390\/biomedicines10092057","volume":"10","author":"JM Nowak","year":"2022","unstructured":"Nowak, J. M., Kopczy\u0144ski, M., Friedman, A., Koziorowski, D. & Figura, M. Microbiota Dysbiosis in Parkinson disease-in search of a biomarker. Biomedicines10(9), 2057. https:\/\/doi.org\/10.3390\/biomedicines10092057 (2022).","journal-title":"Biomedicines"},{"issue":"1","key":"74400_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12883-021-02544-7","volume":"22","author":"G Wu","year":"2022","unstructured":"Wu, G. et al. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson\u2019s disease patients. BMC Neurol.22(1), 13. https:\/\/doi.org\/10.1186\/s12883-021-02544-7 (2022).","journal-title":"BMC Neurol."},{"issue":"18","key":"74400_CR68","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1128\/JB.01780-14","volume":"196","author":"A Heinken","year":"2014","unstructured":"Heinken, A. et al. Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe. J. Bacteriol.196(18), 3289\u20133302. https:\/\/doi.org\/10.1128\/JB.01780-14 (2014).","journal-title":"J. Bacteriol."},{"issue":"8","key":"74400_CR69","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/mds.29128","volume":"37","author":"A Xie","year":"2022","unstructured":"Xie, A. et al. Bacterial butyrate in Parkinson\u2019s disease is linked to epigenetic changes and depressive symptoms. Mov. Disord.37(8), 1644\u20131653. https:\/\/doi.org\/10.1002\/mds.29128 (2022).","journal-title":"Mov. Disord."},{"key":"74400_CR70","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.3390\/ijms23094494","volume":"23","author":"SR Alli","year":"2022","unstructured":"Alli, S. R. et al. The gut microbiome in depression and potential benefit of prebiotics, probiotics and symbiotics: A systematic review of clinical trials and observational studies. Int. J. Mol. Sci23, 4494 (2022).","journal-title":"Int. J. Mol. Sci"},{"issue":"6","key":"74400_CR71","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano, A., Visanji, N. P., Liu, L. W., Lang, A. E. & Pfeiffer, R. F. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol.14(6), 625\u2013639. https:\/\/doi.org\/10.1016\/S1474-4422(15)00007-1 (2015).","journal-title":"Lancet Neurol."},{"issue":"11","key":"74400_CR72","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.tins.2016.09.002","volume":"39","author":"A Sarkar","year":"2016","unstructured":"Sarkar, A. et al. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci.39(11), 763\u2013781. https:\/\/doi.org\/10.1016\/j.tins.2016.09.002 (2016).","journal-title":"Trends Neurosci."},{"key":"74400_CR73","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol.22, 657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6 (2022).","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"74400_CR74","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/mds.29056","volume":"37","author":"R Kim","year":"2022","unstructured":"Kim, R. et al. Serum inflammatory markers and progression of nonmotor symptoms in early Parkinson\u2019s disease. Mov. Disord.37(7), 1535\u20131541. https:\/\/doi.org\/10.1002\/mds.29056 (2022).","journal-title":"Mov. Disord."},{"key":"74400_CR75","doi-asserted-by":"publisher","first-page":"578386","DOI":"10.3389\/fimmu.2021.578386","volume":"12","author":"F Cristofori","year":"2021","unstructured":"Cristofori, F. et al. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: A door to the body. Front. Immunol.12, 578386. https:\/\/doi.org\/10.3389\/fimmu.2021.578386 (2021).","journal-title":"Front. Immunol."},{"issue":"28","key":"74400_CR76","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1080\/10408398.2021.1920884","volume":"62","author":"Y Cheng","year":"2022","unstructured":"Cheng, Y., Liu, J. & Ling, Z. Short-chain fatty acids-producing probiotics: A novel source of psychobiotics. Crit. Rev. Food Sci. Nutr.62(28), 7929\u20137959. https:\/\/doi.org\/10.1080\/10408398.2021.1920884 (2022).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"9","key":"74400_CR77","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/nu14091882","volume":"14","author":"CF Tang","year":"2022","unstructured":"Tang, C. F. et al. Short-chain fatty acids ameliorate depressive-like behaviors of high fructose-fed mice by rescuing hippocampal neurogenesis decline and blood-brain barrier damage. Nutrients14(9), 1882. https:\/\/doi.org\/10.3390\/nu14091882 (2022).","journal-title":"Nutrients"},{"key":"74400_CR78","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/JPD-202298","volume":"11","author":"D Nyholm","year":"2021","unstructured":"Nyholm, D. & Hellstr\u00f6m, P. Effects of Helicobacter pylori on levodopa pharmacokinetics. J. Parkinsons Dis.11, 61\u201369. https:\/\/doi.org\/10.3233\/JPD-202298 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"74400_CR79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12915-020-00876-3","volume":"18","author":"S van Kessel","year":"2020","unstructured":"van Kessel, S. et al. Gut bacterial deamination of residual levodopa medication for Parkinson\u2019s disease. BMC Biol.18, 137. https:\/\/doi.org\/10.1186\/s12915-020-00876-3 (2020).","journal-title":"BMC Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74400-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74400-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74400-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T12:06:41Z","timestamp":1728043601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-74400-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["74400"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-74400-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"3 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the patients gave their written informed consent to the study. The protocol was approved by the Ethics Committee of ASLNAPOLI3SUD on 25\/09\/2018 and registered in ClinicalTrials.gov (ref. no.: NCT04293159), and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23095"}}